Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Reviewing the Potential of Psychedelics for the Treatment of PTSD.

Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (17)

    1. Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex 2026-06-28 · Expand citations
    2. Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy 2026-03-01 · Expand citations
    3. A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder 2025-12-25 · Expand citations
    4. The THRIVE Model of Psychedelic Integration: A Holistic Framework Bridging Indigenous Knowledge and Evidence-Based Practice 2025-10-19 · Expand citations
    5. Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care 2025-09-02 · Expand citations
    6. Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling 2025-06-01 · Expand citations
    7. Regulatory Challenges of Integrating Psychedelics into Mental Health Sector 2025-04-22 · Expand citations
    8. Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans 2025-04-21 · Expand citations
    9. PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin 2024-07-24 · Expand citations
    10. IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME? 2024-06-30 · Expand citations
    11. From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine 2024-05-01 · Expand citations
    12. Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists 2024-01-21 · Expand citations
    13. Psilocybin-Based Breakthroughs in Natural Medicine 2023-04-30 · Expand citations
    14. The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy 2023-02-11 · Expand citations
    15. Psychedelic-Assisted Therapy and Meditative Experience as Factors of Personal Change 2023-01-01 · Expand citations
    16. An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma 2022-01-01 · Expand citations
    17. Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa 2021-06-24 · Expand citations